Literature DB >> 25516918

M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.

Lei Zhao1, Michael Z David2, Elizabeth Hyjek3, Anthony Chang1, Shane M Meehan4.   

Abstract

BACKGROUND AND OBJECTIVES: This study examined kidney biopsies with focal segmental glomerular fibrinoid necrosis to identify early features of pauci-immune necrotizing GN and the primary effector cells mediating initial capillary injury. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Seventeen consecutive kidney biopsies with focal pauci-immune necrotizing GN, obtained over a 6-year period (2007-2012), were studied. Neutrophils and CD68(+), CD163(+), CD3(+), CD56(+), and CD20(+) cells were scored in paraffin sections counterstained with periodic acid-Schiff. Electron microscopy was performed in 15 of 17 biopsies and additional examples of pauci-immune necrotizing GN (n=25). Biopsies with thin basement membrane nephropathy (n=5) served as immunohistologic normal controls.
RESULTS: Biopsies with pauci-immune necrotizing GN had a mean of 10 (range=3-25) normal-appearing glomeruli, a mean of 2 (range=1-5) glomeruli with segmental fibrinoid necrosis, and a mean of 2 (range=1-11) glomeruli with cellular crescents. CD68(+) and CD163(+) macrophages predominated at sites of fibrinoid necrosis in pauci-immune necrotizing GN, exceeding the quantity of neutrophils and T cells (mean scores [SD]=2.5 [0.7] and 2.2 [0.75] versus 0.6 [0.5] and 0.1 [0.3], respectively; P<0.001). B and natural killer cells were rare. Normal-appearing glomeruli in pauci-immune necrotizing GN had significantly more CD68(+) and CD163(+) macrophages than the controls (CD68(+), 0.9 [0.3] versus 0.4 [0.3]; CD163(+), 1 [0.4] versus 0.4 [0.3]; P<0.001). The quantity of other glomerular infiltrates did not differ from controls. The serum creatinine level at biopsy correlated with the glomerular CD68 and neutrophil scores (r=0.74 and r=0.71, respectively; P=0.001) but did not correlate with the extent of fibrinoid necrosis (r=0.36). Macrophages were localized at minute perforations and attenuations of the capillary basement membrane by electron microscopy.
CONCLUSIONS: Early pauci-immune necrotizing GN is characterized by a selective localization of CD163(+) M2 macrophages at sites of glomerular fibrinoid necrosis and in normal-appearing glomeruli. These observations indicate that alternatively activated macrophages are positioned as potential effectors of glomerular injury in the early stages of pauci-immune necrotizing GN and may be potential targets for therapeutic intervention.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  ANCA; GN; macrophages; vasculitis

Mesh:

Substances:

Year:  2014        PMID: 25516918      PMCID: PMC4284408          DOI: 10.2215/CJN.03230314

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  33 in total

Review 1.  CD163 and its expanding functional repertoire.

Authors:  P Akila; V Prashant; M N Suma; S N Prashant; T R Chaitra
Journal:  Clin Chim Acta       Date:  2012-01-27       Impact factor: 3.786

Review 2.  ANCA disease: where is this field heading?

Authors:  Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2010-04-15       Impact factor: 10.121

Review 3.  Basic and translational concepts of immune-mediated glomerular diseases.

Authors:  William G Couser
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 4.  Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases.

Authors:  Neeraja Kambham
Journal:  Adv Anat Pathol       Date:  2012-03       Impact factor: 3.875

5.  Structure and development of the glomerular crescent.

Authors:  T Morita; Y Suzuki; J Churg
Journal:  Am J Pathol       Date:  1973-09       Impact factor: 4.307

6.  Histopathologic classification of ANCA-associated glomerulonephritis.

Authors:  Annelies E Berden; Franco Ferrario; E Christiaan Hagen; David R Jayne; J Charles Jennette; Kensuke Joh; Irmgard Neumann; Laure-Hélène Noël; Charles D Pusey; Rüdiger Waldherr; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

Review 7.  Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Adil H Gasim
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

8.  Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.

Authors:  Amanda-Jane Ruth; A Richard Kitching; Rain Y Q Kwan; Dragana Odobasic; Joshua D K Ooi; Jennifer R Timoshanko; Michael J Hickey; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2006-06-12       Impact factor: 10.121

Review 9.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

10.  Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.

Authors:  Ruth J Pepper; Sally Hamour; Konstantia-Maria Chavele; Sarah K Todd; Niels Rasmussen; Shaun Flint; Paul A Lyons; Kenneth G C Smith; Charles D Pusey; H Terence Cook; Alan D Salama
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

View more
  31 in total

1.  TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.

Authors:  Lukas Bossaller; Anette Christ; Karin Pelka; Kerstin Nündel; Ping-I Chiang; Catherine Pang; Neha Mishra; Patricia Busto; Ramon G Bonegio; Reinhold Ernst Schmidt; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2016-06-27       Impact factor: 5.422

2.  ANCAs are also antimonocyte cytoplasmic autoantibodies.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-16       Impact factor: 8.237

3.  Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis.

Authors:  J P Dos Santos; R Artigiani Neto; C L P Mangueira; R Z Filippi; P S Gutierrez; J Westra; E Brouwer; A W S de Souza
Journal:  Clin Exp Immunol       Date:  2020-07-30       Impact factor: 4.330

Review 4.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

5.  Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis.

Authors:  Cristiane B Dias; Patrícia Malafronte; Jin Lee; Aline Resende; Lectícia Jorge; Cilene C Pinheiro; Denise Malheiros; Viktoria Woronik
Journal:  J Nephrol       Date:  2015-11-30       Impact factor: 3.902

Review 6.  Overview of the Pathogenesis of ANCA-Associated Vasculitis.

Authors:  Hong Xiao; Peiqi Hu; Ronald J Falk; J Charles Jennette
Journal:  Kidney Dis (Basel)       Date:  2015-12-03

Review 7.  Update on ANCA-associated vasculitis: from biomarkers to therapy.

Authors:  Martina Tedesco; Maurizio Gallieni; Francesca Pellegata; Mario Cozzolino; Federico Alberici
Journal:  J Nephrol       Date:  2019-07-12       Impact factor: 3.902

8.  Clinical-pathologic significance of CD163 positive macrophage in IgA nephropathy patients with crescents.

Authors:  Jun Li; Chang-Hua Liu; Bo Gao; Dao-Liang Xu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  Urinary Soluble CD163 in Active Renal Vasculitis.

Authors:  Vincent P O'Reilly; Limy Wong; Claire Kennedy; Louise A Elliot; Shane O'Meachair; Alice Marie Coughlan; Eoin C O'Brien; Michelle M Ryan; Diego Sandoval; Emma Connolly; Gerjan J Dekkema; Jiaying Lau; Wayel H Abdulahad; Jan-Stephan F Sanders; Peter Heeringa; Colm Buckley; Cathal O'Brien; Stephen Finn; Clemens D Cohen; Maja T Lindemeyer; Fionnuala B Hickey; Paul V O'Hara; Conleth Feighery; Sarah M Moran; George Mellotte; Michael R Clarkson; Anthony J Dorman; Patrick T Murray; Mark A Little
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

10.  Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.

Authors:  Joop P Aendekerk; Sjoerd A M E G Timmermans; Matthias H Busch; Judith Potjewijd; Peter Heeringa; Jan G M C Damoiseaux; Chris P Reutelingsperger; Pieter van Paassen
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-17       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.